Deutsche Bank Aktiengesellschaft »

Revance Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2023-12-31 $389k 44k 8.79
2023-09-30 $517k 45k 11.47
2023-06-30 $1.0M 40k 25.31
2023-03-31 $1.9M 58k 32.21
2022-12-31 $2.9M 158k 18.46
2022-09-30 $877k 32k 27.12
2022-06-30 $573k 41k 14.00
2022-03-31 $901k 46k 19.69
2021-12-31 $831k 51k 16.41
2021-09-30 $1.3M 48k 27.71
2021-06-30 $1.9M 63k 29.64
2021-03-31 $3.9M 140k 27.78
2020-12-31 $1.4M 50k 28.21
2020-09-30 $899k 38k 23.81
2020-06-30 $3.3M 135k 24.31
2020-03-31 $2.6M 176k 14.80
2019-12-31 $2.5M 156k 15.93
2019-09-30 $374k 31k 11.97
2019-06-30 $6.4M 506k 12.70
2019-03-31 $5.6M 471k 12.00
2018-12-31 $0 332k 0.00
2018-09-30 $5.8M 234k 24.84
2018-06-30 $7.7M 281k 27.42
2018-03-31 $4.7M 153k 30.76
2017-12-31 $3.7M 129k 29.13
2017-09-30 $3.2M 115k 27.55
2017-06-30 $3.1M 117k 26.06
2017-03-31 $0 17k 0.00
2016-12-31 $0 24k 0.00
2016-09-30 $0 19k 0.00
2016-06-30 $298k 22k 13.44
2016-03-31 $215k 12k 17.33
2015-12-31 $189k 5.6k 33.61
2015-09-30 $675k 23k 28.94
2015-06-30 $2.5M 78k 31.92
2015-03-31 $793k 40k 19.94
2014-12-31 $120k 7.4k 16.20
2014-09-30 $202k 11k 19.18
2014-06-30 $457k 14k 33.44
2014-03-31 $55k 1.8k 31.43